| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.01K | $6.93K | $95.88K | $1.14M | $818.27K |
| SG&A | $258.23K | $223.54K | $274.50K | $399.47K | $430.69K |
| Operating Income | – | – | – | -$2.07M | -$1.99M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$319.14K | -$327.36K | -$591.21K | -$1.65M | -$1.99M |
| EPS (basic) | 0.0000 | 0.0000 | -0.0100 | -0.0200 | -0.0200 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |